Overview

Adiposs SA is a clinical-stage Swiss life science company developing ImageBAT, the first and only medical imaging product for brown fat. It is a platform technology with multiple indications, namely in cancer and obesity. Adiposs' go-to-market focus is on oncology because ImageBAT scan predicts the response to cancer immunotherapy, the emerging gold standard of cancer therapy. The Company has finished phase 1 human clinical trial and is ready to start phase II clinical development in oncology.